Characterization of the Protective HIV-1 CTL Epitopes and the Corresponding HLA Class I Alleles: A Step towards Designing CTL Based HIV-1 Vaccine

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left">HLA</td><td align="center">Total number and as % of total HLAs</td><td align="center">Number of epitope recognized</td><td align="center">% of epitope recognized by HLA in total epitope pool </td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">A</td><td align="center">17 (27%)</td><td align="center">86</td><td align="center">31%</td></tr><tr><td align="left">B</td><td align="center">31 (50%)</td><td align="center">165</td><td align="center">60%</td></tr><tr><td align="left">C</td><td align="center">14 (23%)</td><td align="center">24</td><td align="center">9%</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Advances in Virology

tab5

Table 5

Table 5: Characterization of the Protective HIV-1 CTL Epitopes and the Corresponding HLA Class I Alleles: A Step towards Designing CTL Based HIV-1 Vaccine 

Table 5 | Characterization of the Protective HIV-1 CTL Epitopes and the Corresponding HLA Class I Alleles: A Step towards Designing CTL Based HIV-1 Vaccine 